Boston, MA - Declining cardiac function is associated with lower total brain volume, according to a new report using data from the Framingham Offspring Cohort [1]. The findings are preliminary but ...

Accurately measuring electrical signals and calcium levels in the heart can lead to earlier treatment of potentially fatal conditions, such as heart attack or congestive heart failure. Calcium plays ...

Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for Myosin-Binding Protein C3-associated hypertrophic cardiomyopathy ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

In this cohort study, fine particulate matter (PM2.5) and ozone exposure was independently associated with worse cardiac remodeling and function in patients with breast cancer treated with cardiotoxic ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

The CardioTag™ device, the first multimodal, wearable sensor that simultaneously captures high-fidelity electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals, ...

SAN DIEGO - Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company with a market capitalization of $546 million and strong liquidity metrics according to InvestingPro data, reported four-year ...